Lawmakers Support Medical Marijuana Research For Afflicted Veterans

10 U.S. House members are actively advocating for research into medical marijuana for military veterans as an alternative form of treatment. Recent studies into the positive effects of cannabis on those afflicted with Post Traumatic Stress Disorder (PTSD) prompted interest from the House members and in a letter to Department of Veterans Affairs secretary David Shulkin they stated that the VA “is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD given its access to world class researchers, the population it serves, and its history of overseeing and producing research resulting in cutting-edge medical treatments.” Do you agree that additional research into medical marijuana may be of benefit to veterans that suffer from PTSD among other conditions?

A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.

The U.S. Department of Veterans Affairs (VA) “is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD given its access to world class researchers, the population it serves, and its history of overseeing and producing research resulting in cutting-edge medical treatments,” the group of lawmakers who sit on the House Committee on Veterans’ Affairs wrote on Thursday in a letter to VA Secretary David Shulkin.

Recently, medical cannabis advocates and veterans groups like the American Legion have increased pressure on VA to stop blocking federally-approved researchers from recruiting veterans for research on medical cannabis.

One such study on marijuana’s effects on PTSD has been prevented from reaching veterans at the VA hospital in Phoenix.

“This study needs 50 more participants and the Phoenix VA is in the best possible position to assist by simply allowing principle investigators to brief [VA] medical staff on the progress of the study, and by allowing clinicians to reveal the existence of the study to potential participants,” the Legion wrote to Shulkin last month. “Your immediate attention in this important matter is greatly appreciated. We ask for your direct involvement to ensure this critical research is fully enabled.”

Shulkin has not yet responded to the Legion’s letter, a representative of the group said.

“Time and time again I have heard the stories of veterans who have used marijuana medicinally to help them cope with physical and psychological injuries sustained during their service,” Congressman Tim Walz (D-MN), the highest ranking enlisted servicemember ever to serve Congress, said in a statement about the lawmakers’ new letter to Shulkin. “After hearing from and meeting with veterans and veterans’ advocates from communities across the country, I now know for a fact that research and access to medical marijuana has become a critically important veterans’ issue.”

A number of recent studies indicate that legal marijuana access is associated with reduced opioid overdose and addiction rates.

“At no period of time has research into medical marijuana been as critically important as it is now, as there isn’t a single community in America that hasn’t come face-to-face with our nation’s tragic opioid epidemic,” Walz said. “Few populations have been as hurt by the opioid epidemic as our veterans.”
Shulkin has on a number of occasions indicated that he does see medical potential for marijuana but has consistently incorrectly claimed that Congressional action is needed before he can do anything to increase veterans’ access or expand research.

The House lawmakers, all Democrats, are asking him to respond by November 14.